712
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus

, , , &
Pages 464-474 | Received 13 Apr 2012, Accepted 04 Jul 2012, Published online: 13 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Debojit Bhattacharjee & Vivek Srivastava. (2020) Aspects of 3D printed drugs. Journal of Medical Engineering & Technology 44:8, pages 472-480.
Read now
Rawan Bafail, Mutasem Rawas-Qalaji, Mohamad Rawas-Qalaji & Alhussain Aodah. (2019) Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets. Drug Development and Industrial Pharmacy 45:10, pages 1617-1623.
Read now
Yasmin Thabet, Marta Slavkova & Jörg Breitkreutz. (2018) 10 years EU regulation of pediatric medicines – impact on cardiovascular drug formulations. Expert Opinion on Drug Delivery 15:3, pages 261-270.
Read now
Milica Drašković, Djordje Medarević, Ivana Aleksić & Jelena Parojčić. (2017) In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drug Development and Industrial Pharmacy 43:5, pages 723-731.
Read now
Daniel Sieber, Alessia Lazzari, Julian Quodbach & Miriam Pein. (2017) Applicability of two automated disintegration apparatuses for rapidly disintegrating (mini)tablets. Pharmaceutical Development and Technology 22:2, pages 198-205.
Read now

Articles from other publishers (24)

PADMA SVN, NAGARAJU PAPPULA, V. VASU NAIK & VENKATA RAMANA MURTHY KOLAPALLI. (2023) DEVELOPMENT AND EVALUATION OF GASTRIC FLOATING TABLETS OF RIBOFLAVIN USING BOX-BEHNKEN DESIGN. International Journal of Applied Pharmaceutics, pages 294-302.
Crossref
Thao Tranová, Jan Loskot, Ondřej Navrátil, Witold Brniak & Jitka Mužíková. (2023) Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone. International Journal of Pharmaceutics 636, pages 122838.
Crossref
MAHMOUD H. TEAIMA, HUSSIEN MOHAMED AHMED EL MESSIRY, TASNEEM DAHI OSMAN, MOHAMED A. EL-NABARAWI & DOAA A. HELAL. (2023) THE EFFECT OF CO-PROCESSED EXCIPIENTS DURING FORMULATION AND EVALUATION OF PEDIARIC LEVETIRACETAM ORODISPERSIBLE TABLETS IN RATS. International Journal of Applied Pharmaceutics, pages 318-323.
Crossref
Marcel Kokott, Stefan Klinken, Jörg Breitkreutz & Raphael Wiedey. (2023) Downstream processing of amorphous solid dispersions into orodispersible tablets. International Journal of Pharmaceutics 631, pages 122493.
Crossref
Jolanta Pyteraf, Witold Jamróz, Mateusz Kurek, Urszula Bąk, Jan Loskot, Daniel Kramarczyk, Marian Paluch & Renata Jachowicz. (2023) Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole. International Journal of Pharmaceutics 630, pages 122444.
Crossref
Jennifer Kuck & Jörg Breitkreutz. (2022) Impact of lubrication on key properties of orodispersible minitablets in comparison to conventionally sized orodispersible tablets. European Journal of Pharmaceutics and Biopharmaceutics 180, pages 71-80.
Crossref
Amber Nawab, Sehar Iqtidar, Dr. Subia Jamil & Javeria Shiekh. (2022) Co-processed excipients-A step towards better drug product performance. Co-processed excipients-A step towards better drug product performance.
Kai Bin Liew, Long Chiau Ming, Bey-Hing Goh & Kok Khiang Peh. (2022) Fast Melt Cocoa Butter Tablet: Effect of Waxes, Starch, and PEG 6000 on Physical Properties of the Preparation. Molecules 27:10, pages 3128.
Crossref
Kacper Kroczek, Paweł Turek, Damian Mazur, Jacek Szczygielski, Damian Filip, Robert Brodowski, Krzysztof Balawender, Łukasz Przeszłowski, Bogumił Lewandowski, Stanisław Orkisz, Artur Mazur, Grzegorz Budzik, Józef Cebulski & Mariusz Oleksy. (2022) Characterisation of Selected Materials in Medical Applications. Polymers 14:8, pages 1526.
Crossref
Faisal Al-Akayleh, Nisrein Jaber & Mayyas Al-Remawi. (2020) Designing, Preparation, and Evaluation of Orodispersible Chitosan Anionic Salt Tablets. Journal of Pharmaceutical Innovation 17:1, pages 129-141.
Crossref
Thao Tranová, Oliver Macho, Jan Loskot & Jitka Mužíková. (2022) Study of rheological and tableting properties of lubricated mixtures of co-processed dry binders for orally disintegrating tablets. European Journal of Pharmaceutical Sciences 168, pages 106035.
Crossref
Pratik Chatterjee & Chinmay Chakraborty. 2022. Intelligent Healthcare. Intelligent Healthcare 395 420 .
Marcel Kokott, Ard Lura, Jörg Breitkreutz & Raphael Wiedey. (2021) Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 122-130.
Crossref
Adina Magdalena Musuc, Valentina Anuta, Irina Atkinson, Iulian Sarbu, Vlad Tudor Popa, Cornel Munteanu, Constantin Mircioiu, Emma Adriana Ozon, George Mihai Nitulescu & Mirela Adriana Mitu. (2021) Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine. Pharmaceutics 13:6, pages 915.
Crossref
Neel Desai, Andrew Redfearn, Graeme MacLeod, Catherine Tuleu, Ben Hanson & Mine Orlu. (2020) How Do Orodispersible Tablets Behave in an In Vitro Oral Cavity Model: A Pilot Study. Pharmaceutics 12:7, pages 651.
Crossref
Petra Svačinová, Barbora Vraníková, Martin Dominik, Jan Elbl, Sylvie Pavloková, Roman Kubalák, Pavlína Kopecká & Aleš Franc. (2019) Comprehensive study of co-processed excipients F- Melts®: Flow, viscoelastic and compacts properties. Powder Technology 355, pages 675-687.
Crossref
Witold Jamróz, Joanna Szafraniec, Mateusz Kurek & Renata Jachowicz. (2018) 3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges. Pharmaceutical Research 35:9.
Crossref
Milica Drašković, Sandra Cvijić, Svetlana Ibrić & Jelena Parojčić. (2018) Characterization of orodispersible tablets and orodispersible films. Arhiv za farmaciju 68:4, pages 839-859.
Crossref
Ahmed A. El-Shenawy, Mahmoud M. Ahmed, Heba F. Mansour & Saleh Abd El Rasoul. (2017) Torsemide Fast Dissolving Tablets: Development, Optimization Using Box–Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment. AAPS PharmSciTech 18:6, pages 2168-2179.
Crossref
Jonas Buck, Jörg Huwyler, Peter Kühl & Angela Dischinger. (2016) Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping. Pharmaceutical Research 33:8, pages 2043-2055.
Crossref
Witold Brniak, Renata Jachowicz & Przemyslaw Pelka. (2015) The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs). Saudi Pharmaceutical Journal 23:4, pages 437-443.
Crossref
Witold Brniak, Ewelina Maślak & Renata Jachowicz. (2015) Orodispersible films and tablets with prednisolone microparticles. European Journal of Pharmaceutical Sciences 75, pages 81-90.
Crossref
Marta Slavkova & Jörg Breitkreutz. (2015) Orodispersible drug formulations for children and elderly. European Journal of Pharmaceutical Sciences 75, pages 2-9.
Crossref
John Rojas. 2015. Excipient Applications in Formulation Design and Drug Delivery. Excipient Applications in Formulation Design and Drug Delivery 589 612 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.